Melanoma

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
CO39262A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION−POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMAMcWhirter, Dr ElaineOpenNCT02908672
ME.13A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)McWhirter, Dr ElaineOpenNCT02821013
MEC.5A PHASE III RANDOMIZED TRIAL COMPARING HIGH DOSE INTERFERON TO MK-3475 (PEMBROLIZUMAB) IN PATIENTS WITH HIGH RISK RESECTED MELANOMAMcWhirter, Dr ElaineOpenNCT02506153
KEYNOTE 022A Phase I/II Study to Assess the Safety and Efficacy of MK-3475 in Combination with
Trametinib and Dabrafenib in Subjects with Advanced Melanoma
McWhirter, Dr ElaineOpenNCT02130466
Download PDF